Digital
On AI and computational support of biochemistry, with Alan R...
Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
R&D
Harnessing the cell's own degradation machinery, with Benedi...
Benedict Cross, Chief Technology Officer at PhoreMost, discusses targeted protein degradation.
Oncology
How blood tests can inform cancer treatment decisions, with ...
Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.
Patients
The NHS, system burden, and a transformation prescription, w...
Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.
R&D
On CB1s as an alternative to GLP-1s, with Punit Dhillon
In a new pharmaphorum podcast, Punit Dhillon, CEO of Skye Bioscience, discusses CB1 inhibitor antibodies in the obesity space.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
